公开(公告)号：US20240091341A1

公开(公告)日：2024-03-21

申请号：US18032545

申请日：2021-10-18

Applicant: THE RESEARCH FOUNDATION FOR MICROBIAL DISEASES OF OSAKA UNIVERSITY

Inventor： Yasuo YOSHIOKA

IPC: A61K39/215 ,  A61P37/04 ,  C07K14/005 ,  C12N9/24

CPC classification number: A61K39/215 ,  A61P37/04 ,  C07K14/005 ,  C12N9/2402 ,  C12Y302/01018 ,  A61K2039/543

Abstract: The present invention provides a new component that is useful as a SARS-CoV-2 vaccine antigen that uses as a target a receptor binding domain of SARS-CoV-2. The present invention contains the fusion protein, which includes hemagglutinin and a receptor binding domain of SARS-CoV-2, and a vaccine containing the fusion protein.